uses for tirzepatide FDA approval Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Injection

The FDA ended compounding discretion for tirzepatide in March 2025, maintaining discretion for semaglutide

Sticky cholesterol obstructs blood flow in the form of plaques

142 Kaltenbach TE, Graeter T, Oeztuerk S, Holzner D, Kratzer W, Wabitsch M, et al

This lightweight, fast-absorbing serum blends science-backed ingredients with gentle skincare technology to deliver visible results without irritation

In the current study, we first identified BDNF, as a endogenous antagonist targeting the extracellular LRR domain of TLR4

The mixed results emphasize the need for further research to determine how GLP-1 medications may be used to treat OUD and other substance use disorders